Clinical Trials Directory

Trials / Conditions / Evidence of Liver Transplantation

Evidence of Liver Transplantation

30 registered clinical trials studyying Evidence of Liver Transplantation.

StatusTrialSponsorPhase
CompletedEvaluate the Efficacy and Safety of the ADVAGRAF®
NCT04763096
Linical KoreaPhase 4
UnknownProtective Effects of Dexmedetomidine on Myocardial Injury During Liver Transplantation
NCT03013634
Tianjin First Central HospitalN/A
CompletedCombination of Cryosurgery and NK Immunotherapy for Tumors in Transplanted Liver
NCT02849015
Fuda Cancer Hospital, GuangzhouPhase 1 / Phase 2
UnknownClinical Trial of Hydrogen-Rich Celsior Solution Applied in Aging DBD Liver/Kidney Transplantation
NCT02613195
RenJi HospitalPhase 3
Active Not RecruitingQuantifying Steatosis in Liver Transplant Donors
NCT02579408
The University of Hong Kong
CompletedDetermining Equivalence Dose for Oral Versus Sublingual Administration of Tacrolimus in Hepatic Receptors
NCT02608606
Pontificia Universidad Catolica de ChileN/A
UnknownSafety, Efficacy of Eglandin® in Living Donor Liver Transplanted Patient (PROVISION)
NCT02350218
Asan Medical CenterPhase 2
UnknownManagement of Perioperative Coagulopathy With Thromboelastometry (ROTEM) in Liver Transplant
NCT02239991
Hospital Israelita Albert EinsteinN/A
UnknownChanges of Macrophage Migration Inhibitory Factor During Orthotopic Liver Transplantation
NCT02695979
Medical University of Vienna
UnknownUsefulness of Alpha-GST in Liver Transplantation
NCT02451046
Beaujon Hospital
CompletedClinical Benefits of B-Flow Ultrasound
NCT02008097
University of WashingtonN/A
UnknownImpact of Melatonin in the Pretreatment of Organ Donor and the Influence in the Evolution of Liver Transplant.
NCT01860716
Aragon Institute of Health SciencesPhase 3
CompletedUses of Immunosuppression Therapy in Patients With Liver Transplantation
NCT01834690
Chang Gung Memorial Hospital
UnknownHuman Mesenchymal Stem Cells Induce Liver Transplant Tolerance
NCT01690247
Beijing 302 HospitalPhase 1
CompletedPilot Study of Hepatitis C Virus Entry Inhibitor (ITX 5061) in Liver Transplant Recipients
NCT01292824
University of BirminghamPhase 1
UnknownAutologous Transplantation of Mesenchymal Stem Cells for Treatment of Patients With Onset of Type 1 Diabetes
NCT01157403
Lu DebinPhase 2 / Phase 3
CompletedSafety Study of Liver Natural Killer Cell Therapy for Hepatoma Liver Transplantation
NCT01147380
Seigo NishidaPhase 1
CompletedRaltegravir in Patients With End Stage Liver Disease and in Transplant Recipients
NCT01022476
ANRS, Emerging Infectious DiseasesPhase 1 / Phase 2
UnknownThe Study to Evaluate Efficacy and Safety of MY-REPT Capsule in Primary, Liver Transplantation Recipients (MYL
NCT01766518
Chong Kun Dang PharmaceuticalPhase 4
UnknownProspective Liver Tumor (ProLiT) Database
NCT01607788
University of Geneva, Switzerland
CompletedStudy of Glycemic Control on Liver Transplantation Outcomes
NCT01211730
Northwestern UniversityPhase 4
CompletedStudy of Factors Predicting Tumor Recurrence After Liver Transplantation for Hepatocellular Carcinoma (HCC)
NCT01198704
Assistance Publique - Hôpitaux de Paris
TerminatedA Pilot Trial of Pediatric Liver Transplantation Without Steroids
NCT00694408
Birmingham Women's and Children's NHS Foundation TrustPhase 3
CompletedStudy to Establish Whether the Use of T-Tube in Bile Duct Anastomosis in Liver Transplantation Decreases Morbi
NCT01546064
Hospital Universitario La FeN/A
TerminatedRandomized Phase II Study of Hepatitis C Immune Globulin Intravenous (Human), Civacir(TM), in Liver Transplant
NCT00473824
ADMA Biologics, Inc.Phase 2
CompletedImmunogenicity of HPV Vaccine in Immunosuppressed Children
NCT02263703
The University of New South WalesPhase 3
CompletedSafety and Efficacy of Alemtuzumab in Pediatric Intestinal Transplantation
NCT01208337
University of PittsburghPhase 2
TerminatedSwitch From Tacrolimus to Cyclosporin in the Treatment of Recurrent Hepatitis C After Liver Transplantation
NCT00375895
Rennes University HospitalPhase 3
CompletedCefepime Pharmacokinetics in Liver Transplant Recipients in an Intensive Care Unit
NCT00177931
University of Pittsburgh
TerminatedReduction of Tacrolimus Dose in Association With Mycophenolate Mofetil After Liver Transplantation
NCT00151632
Rennes University HospitalPhase 3